Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
Hopefully, they can get a market listing in 2024 but it will be a long road till they can get FDA approval.
Here is a link to the FDA site if you want to look and are still in this world and need to look.
https://www.fda.gov/medical-devices/device-approvals-denials-and-clearances/recently-approved-devices
What of all these other companies Stuart is involved with and will there be any reward for long-suffering CIC shareholders?
A similar theme that Stuart has been weaving for years.
Live Long and Prosper....
Https://www.securitisation.com/copy-of-securitisation-platform
Can you post a link to CIC Group on Linkedin?
If this link does not work the PDF should be showing on the Innomed website soon.
https://apis.mail.yahoo.com/ws/v3/mailboxes/@.id==VjN-2mFi47XWPM-qZeZS37jaXC3ieV8zMVgmCzZjwMIxVJiwsJ_-O8z7iO6TRKkPJvRXGl2LEeEb8L4Fd0GBJs5fOA/messages/@.id==AMzh_rEhz6vDZUmWBQEhENTq8Fs/content/parts/@.id==2.2/refresh?appid=YMailNorrinLaunch&ymreqid=edf9adfa-3430-0c4e-1cb9-e40000013f00
Ask Stuart......He should know if it is still possible.
I have some electronic certificates that I can print but the shares still show in my Barclays account.
Three years to wait for CIC Gold? More like thirty years at this rate. Not in my lifetime.
Thanks for the new info.
Https://www.globenewswire.com/news-release/2023/07/20/2708138/0/en/Gorilla-Technology-Enters-Strategic-Relationship-with-British-Telecom-for-AI-Powered-Innovative-Smart-Port-Solution.html
"LONDON, July 20, 2023 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, today announced a strategic relationship with British Telecom (BT) to deliver an innovative Container Identification and Container Damage Detection solution. This groundbreaking collaboration, which is being actively deployed and tested at the Port of Tyne in Northern England, combines Gorilla’s expertise in video analytics with BT’s extensive network infrastructure, enabling a comprehensive solution that addresses the critical needs of the logistics industry."
Thank Ian,
Filing in two weeks updated prospectus with Q2 2023.
Still progressing, all I can say at present.
Stuart
Has anyone any info to report?
sparty on ADVFN seems to think LSE closed down this forum.
Thanks for the heads up on 13energy also listed in Canada so I can invest.
Added to my watchlist for now until cash is available.
https://firmeneintrag.creditreform.de/1313/9370423921/CIC_FUND_SECURITISATION_SA
https://www.securitisation.com/
I notice that the site was updated last August and is more comprehensive.
Thanks Ian,
CIC entities still remain private.
You have dividend share in Innomed Tech Ltd.
Innomed Tech is filing an updated version of its prospectus in the next week or so now advanced. I will forward that as soon as I have filed it and becomes public. CIC Fund Securitisation S.A has approved Euro 5,000,000 debt finance in September 2022. By the 31 Jan 2023 Innomed Tech drew down nearly Euro 1,500,000. and will be reflected in the Feb 2023 prospectus.
CIC Fund Securitisation S.A. has Euro 875,000,000 in deposits for debt finance lending and is making significant lender contracts to which CIC Capital Ltd will be taking those client entities public.
CIC Monetization SA (Luxemburg) has been in development for three years now and CIC Capital Ltd along with Mcquary Bank and JP Morgan is talking the company public in a bought deal in US AT 450 Million. 52% of funds is allocated to buy out 52% equity holding of its single shareholder.
Thank all I can say at this point.
Many thanks
Kind Regards,
Stuart J. Bromley
Mobile Global +44 (0)731 1400014
www.CICCapital.com
www.Securitisation.com
19-25, Rue des Capucins, L-1313 Luxembourg
https://www.globenewswire.com/en/news-release/2022/12/09/2571128/0/en/Foley-Catheters-Market-Size-to-Hit-USD-6-87-Billion-by-2030-at-7-80-CAGR-Report-by-Market-Research-Future-MRFR.html
For info about Innomed's prospective business.
I am inclined to agree with you.
Innomed does not inspire me much with its management, don't see many Ph.D.s and MD's there.
Finding a winner in the thousands of medical/ biotech stocks listed in Canada/ USA can be very difficult.
If Stuart can come up with more customers for his financial services there may be some hope but in the present markets not easy.
CIC Gold never got to buy the mine and probably now has nothing but a bit of cash in a tin can. Some History.......
Overseas Market
Mogi: Barsbold Ulambayar (MPP) is the former environment minister, here's his self-profile, also behind the group that sold Khushuut to Mongolia Energy Corp. CICG trading suspension lifts today
LSE-Listed CIC Gold Proposes Reverse Take Over of Gobi Minerals
November 6 -- CIC Gold (LSE: CICG) announced a suspension of trading in the Company's shares on November 3, 2015 as the Company was in discussions regarding a proposed acquisition (the "Proposed Acquisition").
The Proposed Acquisition, if exchanged and completed, would constitute a reverse takeover under the Listing Rules. As the Company was unable to provide a full disclosure under Rule 5.6.15 of the Listing Rules, the Company requested a suspension of trading in its shares.
The Company is pleased to advise that the board of directors (the "Board") of the Company have agreed with the vendors to progress the acquisition of Gobi Minerals Limited for a consideration of £5,600,000 payable by the issue of 280,000,000 shares each with a half warrant to the vendors.
Gobi Minerals Limited collectively own a 100% interest (the "Interest") in mineral title Tsagaan Suvarga gold and copper situated in the South Gobi region of Mongolia located in the territory of Mandakh soum, Dornogovi aimag, 560 km from Ulaanbaatar city, known as Gobi Gold Project. It is located near Mongolian Alt Corporation now in production. The mineral lease has no proven reserves or resources and is considered green field.
The Proposed Acquisition will be subject to a number of conditions including due diligence, the production of a satisfactory Competent Person's Report, documentation, the raising of additional equity finance, the publication of a prospectus, the approval to the issue of new shares as consideration for the Proposed Acquisition by shareholders and Admission of the Company's enlarged share capital to the Main Market.
Board Changes and Management
HE Barsbold Ulambayar, who is an Independent Non Executive Director has been appointed Executive Director and Chief Operating Officer with immediate effect. Dr. Geoffrey P. Cowley, the previous Chief Executive, has been appointed Non Executive Technical Director.
Mr. D. Garamjav, who discovered the potential mineral resources in the lease area, will be appointed principal geologist upon the completion of the Proposed Acquisition. Mr. D. Garamjav discovered the world class Oyu Tolgoi gold copper deposit being developed by Rio Tinto/Ivanhoe.
CIC Gold has appointed Dr. Earl W. Abbott Independent Consulting Geologist to produce a Technical Competent Persons Report on the Interest. The Company then will conduct mineral asset de risk works and seek to divest its interests.
The de-risking phase may include some of the following actions:
· Compile a complete detailed technical report to Canadian NI 43-101 report;
Part2
Usual practice for a Company of our status is for the Regulator to require a Sponsor. Due to the cost involved, the fact that the prospectus is non-offering (not raising capital) and the experience of the Company’s management and Board of Directors, the Company will seek a derogation not to have a regulated Sponsor. There is no certainty the derogation will be granted. The Appointment and Sponsor review can take up to three months.
2. What is the management performance since appointment on April 15, 2020?
The Company is pleased to provide the achievements of management since their appointment which became effective from April 15, 2020 where they replaced Board control from Innovative Medicine Partners, LLC (“IMP”).
Management and the Board of Directors have focussed on implementing proper stewardship on capital raised, noting that cash of US$3,800 at the time of assuming their positions was not sufficient to pay liabilities.
The objectives of the team, consisting of new and some legacy people, were and remain to increase shareholder value by:
· Establishing a governance framework
. Addressing legacy issues / conflict-of-interest / administrative lapses
· Preparing and secure listing of the Company
· Securing funding for activities and to meet liabilities
· Securing Patents in appropriate jurisdiction
· Acquiring FDA approval
· Completing design and development of the product
The table 2 below details the Boards performance and effective use of investor funds. The average monthly burn rate (amount of expenses per month) post new management is US$65,930 compared to US$186,167 under previous management.
Tabe 2
3. What is the Company target share price?
The peer companies used for the derivative analysis by the auditor as detailed in question 1 above shows at our current progression a share price between US$2.20 TO US$36.20 with a share price volatility of 22.2% (price rise or fall)
The Companies target share price is:
I) Short term US$0.60 to $1.20
II) medium term US$2.80 to $8.50
Please note that the Warrants issued has a doubling effect on return and investors.For future tax consideration investors should seek appropriate tax advice and can use the following method of Investment return calculation:
Shares issued + warrants multiply by share price subtract money paid = investment return
For US $100,000 subscription, shares issued 344,828:
344,828 (shares) + 344,828 (warrants) x 1.20 (target share price) – 200,000 (investment plus warrant exercise) = US$627,586
(capital again after deduction of cash investment)
www.InnomedTec.com
Billy Williams Disclosure Officer/Director +1 251 786 4695 BWilliams@InnomedTec.com
Repost of the info.........courtesy of Sparty on ADVFN Part 1
This share holder up date is response to questions being asked by our shareholders:
1 What is the expected listing date?;
2 What is the management performance since appointment on April 15, 2020?;and
3. What is the expected share trading price and share holder return?
1. What is the expected listing date?
The Company’s is not permitted or unable to promote an expected listing date.
The regulatory reviews of the prospectus are largely complete save for the review of any requirement for updated financial statements. The listing timetable is now solely on the regulatory review outcomes and our response to any additional requirement that are imposed beyond the standard form prospectus that the Company has provided. The Company can disclose matters that have impacted the timing to date. Initial reviews have required ten (10) different sets of financial statements to meet regulatory acceptance given the complexity of transactions and intangible asset valuations.
The initial filing was made in January 2021.
A three-month delay in late 2021 was due to the request to calculate and disclose a cost in the financial statements for the shareholder protection provision (Top Up) against a potential share price falling below US$0.29. This required a complex derivative calculation and an analysis of the volatility of listed peer companies over the preceding two years. The Derivative Cost is disclosed in the financial statements from Q3 2021. Q3 Financial statements reviewed with the auditor is a precedent interim financial statements and has been valuable in timely filings of Q1 2022 and most recently Q2 2022.
The Company has engaged with the Regulator throughout the first quarter. Subsequent to Q1 2021, the Regulator paused review until the completion of the independent audit of the 31 December 2021 Financial Statements that was completed in May 2021. In June 2022 there was a requirement for Q1 2022 Financial Statement to be submitted. The Company at the time of this shareholder update has completed Q2 2022 Financial statements and will be filed shortly. the Regulator also requires the quarterly financial statements to be submitted with a confirmation and comfort letter from the Company auditors, again a time and cost imposition.
RSM Canada, the Company auditors, have been very focused to speed up their review processes required because of the significant judgements required in our financial statement disclosures through derivative analysis. The depth of knowledge that they now have is of great assistance to the Company’s ability to respond to the Regulator’s requirements more quickly.
The Regulator has now requested the Share Purchase Agreement (former Class two members) be updated to meet their requirements. Those affected will receive an email of changes requested by the regulators.
Recent postings on this board have been removed.........why?????
Just received the update from Billy Williams forwarded to me by Stuart.